Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Generation Bio Co. (GBIO)
NASDAQ:GBIO
Holding GBIO?
Track your performance easily
GBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.86 - $4.65
Previous Close$2.59
Volume35.02K
Average Volume (3M)118.13K
Market Cap
$188.88M
Enterprise Value$49.87M
Total Cash (Recent Filing)$216.94M
Total Debt (Recent Filing)$93.96M
Price to Earnings (P/E)―
Beta2.65
Next Earnings
Nov 07, 2024EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.39
Shares Outstanding66,741,175
10 Day Avg. Volume81,660
30 Day Avg. Volume118,128
Standard Deviation0.31
R-Squared0.19
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.50
Price to Sales (P/S)13.37
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.79
Enterprise Value/Gross Profit8.45
Enterprise Value/Ebitda-0.40
Forecast
1Y Price Target
$8.00Price Target Upside182.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Generation Bio News
Bulls Say, Bears Say
Bulls Say
Collaborations And PartnershipsEncouraged by the progress in the collaboration with MRNA in which GBIO is eligible to receive up to $1.8B in milestone payments upon specified achievements.
Financial HealthCurrent cash on hand should fund operations into H2:27, aligning with updated guidance.
Gene Therapy AdvancementsLatest updates at ASGCT across all aspects of GBIO's gene therapy platform showed increased cell specificity, lower immunogenicity & dose-dependent protein expression across cell types & models.
Bears Say
EarningsGeneration Bio reported a Q1 operating loss of $78M due to a one-time loss on the termination of their manufacturing facility lease of $57M.
Financial PerformanceThe company recognized a one time non-cash charge of $56M for terminating a manufacturing facility lease.
Stock RatingAbsent a clear timeline to translation of a lead program into NHPs or an IND, maintaining a Market Perform rating and seeing shares as fairly valued at current levels.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GBIO FAQ
What was Generation Bio Co.’s price range in the past 12 months?
Generation Bio Co. lowest stock price was $0.86 and its highest was $4.65 in the past 12 months.
What is Generation Bio Co.’s market cap?
Currently, no data Available
When is Generation Bio Co.’s upcoming earnings report date?
Generation Bio Co.’s upcoming earnings report date is Nov 07, 2024 which is in 49 days.
How were Generation Bio Co.’s earnings last quarter?
Generation Bio Co. released its earnings results on Aug 07, 2024. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.274 by -$0.036.
Is Generation Bio Co. overvalued?
According to Wall Street analysts Generation Bio Co.’s price is currently Undervalued.
Does Generation Bio Co. pay dividends?
Generation Bio Co. does not currently pay dividends.
What is Generation Bio Co.’s EPS estimate?
Generation Bio Co.’s EPS estimate is -$0.28.
How many shares outstanding does Generation Bio Co. have?
Generation Bio Co. has 66,741,170 shares outstanding.
What happened to Generation Bio Co.’s price movement after its last earnings report?
Generation Bio Co. reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.274. Following the earnings report the stock price went up 8.108%.
Which hedge fund is a major shareholder of Generation Bio Co.?
Among the largest hedge funds holding Generation Bio Co.’s share is Baker Bros Advisors LP. It holds Generation Bio Co.’s shares valued at 3M.
---
Generation Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (182.69% Upside)
$8.00 (182.69% Upside)
Hedge Fund Trend
Increased
By 835.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 10.2%
Last 30 Days ▼ 10.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.89%
12-Months-Change
Fundamentals
Return on Equity
-85.71%
Trailing 12-Months
Asset Growth
-34.48%
Trailing 12-Months
Company Description
Generation Bio Co.
Generation Bio Co is a genetics medicine company which is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases.
---
GBIO Stock 12 Month Forecast
Average Price Target
$8.00
▲(182.69% Upside)
Technical Analysis
Best Analysts Covering GBIO
1 Year
---